1-5 of 5
Weili Sun, MD, PHD
Close
Sort by
Journal Articles

Response to Venetoclax and Hypomethylating Agents Among Prognostic Risk Groups and Genetic Subtypes of Acute Myeloid Leukemia

Ibrahim Aldoss, MD, Dongyun Yang, PhD, Raju Pillai, MD, James F Sanchez, PhD, Ahmed Aribi, MD, Haris Ali, MD, Karamjeet S Sandhu, MD, Monzr Al Malki, MD, Matthew Mei, MD, Amandeep Salhotra, MD, Samer K. Khaled, MD, Ryotaro Nakamura, MD, Weili Sun, MD PhD, Margaret R O'Donnell, MD, David S Snyder, MD, Anthony S. Stein, MD, Stephen J Forman, Guido Marcucci, Vinod A. Pullarkat, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 334.
https://doi.org/10.1182/blood-2018-99-113670
Published: 2018
Journal Articles

Inhibition of PRMT1 Mediated FLT3 Arginine Methylation As a Potent Therapeutic Strategy for MLL-r ALL

Yinghui Zhu, PhD, Xin He, PhD, Haojie Dong, PhD, Jie Sun, PhD, Hanying Wang, PhD, Lei Zhang, PhD, Yunan Miao, PhD, Jian Jin, PhD, Yudao Shen, PhD, Jianjun Chen, PhD, Markus Muschen, MD, Chun-Wei Chen, PhD, Marina Y. Konopleva, MD PhD, Weili Sun, MD PhD, Bin Zhang, PhD, Ya-Huei Kuo, PhD, Nadia Carlesso, MD PhD, Guido Marcucci, Ling Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 892.
https://doi.org/10.1182/blood-2018-99-115139
Published: 2018
Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Stephen P. Hunger, MD, Vaskar Saha, MD PhD, Meenakshi Devidas, Maria Grazia Valsecchi, Julie Gastier Foster, Gianni Cazzaniga, PhD, Shalini C. Reshmi, PhD, Michael Borowitz, MD PhD, Anthony Moorman, Nyla A. Heerema, PhD, Andrew J. Carroll, III, PhD, Phillip Barnette, M. Monica Monica Gramatges, MD, Kelly Maloney, MD, Weili Sun, MD PhD, Rene Swanink, Amanda Termuhlen, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Lewis B. Silverman, MD, Martin Schrappe, MD PhD, Kirk R. Schultz, William Slayton, MD, Diane Healey, Andrea Biondi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 98.
https://doi.org/10.1182/blood.V130.Suppl_1.98.98
Published: 2017
Journal Articles

HLA-Haploidentical Stem Cell Transplant with Pre-Transplant Immunosuppression for Patients with Sickle Cell Disease

Anna B Pawlowska, MD, Nicole Karras, MD, Jerry C Cheng, MD, Weili Sun, MD PhD, Leo D Wang, MD PhD, Alison D Bell, DNP, CPNP, Lisa Gutierrez, PNP, Joseph Rosenthal, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5478.
https://doi.org/10.1182/blood.V130.Suppl_1.5478.5478
Published: 2017
Journal Articles

The Combined Expression of AML1-ETO and Oncogenic RAS Is Insufficient To Induce Acute Myeloid Leukemia (AML).

Christian Flotho, MD, Weili Sun, MD, PHD, Sheila Shurtleff, PHD, Shouli Yang, PHD, James R. Downing, MD
Journal: Blood
Blood (2004) 104 (11): 2557.
https://doi.org/10.1182/blood.V104.11.2557.2557
Published: 2004